Associated Papers
Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer.
Mezquita L et al.
British Journal of Cancer, 2024
Discovering Deleterious Single Nucleotide Polymorphisms of Human AKT1 Oncogene: An In Silico Study.
Zhang R et al.
Life (basel, Switzerland), 2023
37511907 (PubMed )
Supplement: life-13-01532-s001.zip › Supplementary_Table_S2.pdf
Clinicopathological and molecular characteristics of patients with hypermutant lung cancer: A retrospective cohort study.
Zhang H et al.
Oncology Letters, 2021
33692861 (PubMed )
Supplement: Supplementary_Data.pdf
Prediction of a highly deleterious mutation E17K in AKT-1 gene: An in silico approach.
Khan I et al.
Biochemistry and Biophysics Reports, 2017
Computational identification of significant missense mutations in AKT1 gene.
Shanthi V et al.
Cell Biochemistry and Biophysics, 2014
Select a paper to view details